Software - Application
Compare Stocks
2 / 10Stock Comparison
LAW vs LFST
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
LAW vs LFST — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Software - Application | Medical - Care Facilities |
| Market Cap | $252M | $3.43B |
| Revenue (TTM) | $162M | $1.49B |
| Net Income (TTM) | $-43M | $23M |
| Gross Margin | 74.9% | 21.7% |
| Operating Margin | -28.1% | 3.0% |
| Forward P/E | — | 121.1x |
| Total Debt | $0.00 | $194M |
| Cash & Equiv. | $20M | $249M |
LAW vs LFST — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 21 | May 26 | Return |
|---|---|---|---|
| CS Disco, Inc. (LAW) | 100 | 10.0 | -90.0% |
| LifeStance Health G… (LFST) | 100 | 32.5 | -67.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: LAW vs LFST
Each card shows where this stock fits in a portfolio — not just who wins on paper.
LAW is the clearest fit if your priority is income & stability and sleep-well-at-night.
- beta 0.96
- Lower volatility, beta 0.96, current ratio 3.78x
- Beta 0.96, current ratio 3.78x
LFST carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 13.9%, EPS growth 113.3%, 3Y rev CAGR 18.3%
- -59.6% 10Y total return vs LAW's -90.3%
- 13.9% revenue growth vs LAW's 8.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 13.9% revenue growth vs LAW's 8.3% | |
| Quality / Margins | 1.6% margin vs LAW's -26.3% | |
| Stability / Safety | Beta 0.96 vs LFST's 1.20 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +60.6% vs LAW's +9.5% | |
| Efficiency (ROA) | 1.1% ROA vs LAW's -25.2%, ROIC 1.2% vs -34.0% |
LAW vs LFST — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
LAW vs LFST — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
LFST leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
LFST is the larger business by revenue, generating $1.5B annually — 9.2x LAW's $162M. LFST is the more profitable business, keeping 1.6% of every revenue dollar as net income compared to LAW's -26.3%. On growth, LFST holds the edge at +21.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $162M | $1.5B |
| EBITDAEarnings before interest/tax | -$41M | $100M |
| Net IncomeAfter-tax profit | -$43M | $23M |
| Free Cash FlowCash after capex | -$19M | $179M |
| Gross MarginGross profit ÷ Revenue | +74.9% | +21.7% |
| Operating MarginEBIT ÷ Revenue | -28.1% | +3.0% |
| Net MarginNet income ÷ Revenue | -26.3% | +1.6% |
| FCF MarginFCF ÷ Revenue | -11.9% | +12.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +14.3% | +21.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +21.1% | — |
Valuation Metrics
LAW leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $252M | $3.4B |
| Enterprise ValueMkt cap + debt − cash | $232M | $3.4B |
| Trailing P/EPrice ÷ TTM EPS | -5.52x | 442.50x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 121.07x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 41.98x |
| Price / SalesMarket cap ÷ Revenue | 1.60x | 2.41x |
| Price / BookPrice ÷ Book value/share | 1.92x | 2.28x |
| Price / FCFMarket cap ÷ FCF | — | 31.20x |
Profitability & Efficiency
LFST leads this category, winning 6 of 7 comparable metrics.
Profitability & Efficiency
LFST delivers a 1.6% return on equity — every $100 of shareholder capital generates $2 in annual profit, vs $-33 for LAW. On the Piotroski fundamental quality scale (0–9), LFST scores 7/9 vs LAW's 4/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -32.7% | +1.6% |
| ROA (TTM)Return on assets | -25.2% | +1.1% |
| ROICReturn on invested capital | -34.0% | +1.2% |
| ROCEReturn on capital employed | -33.4% | +1.3% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 |
| Debt / EquityFinancial leverage | — | 0.13x |
| Net DebtTotal debt minus cash | -$20M | -$55M |
| Cash & Equiv.Liquid assets | $20M | $249M |
| Total DebtShort + long-term debt | $0 | $194M |
| Interest CoverageEBIT ÷ Interest expense | — | 3.30x |
Total Returns (Dividends Reinvested)
LFST leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LFST five years ago would be worth $4,041 today (with dividends reinvested), compared to $970 for LAW. Over the past 12 months, LFST leads with a +60.6% total return vs LAW's +9.5%. The 3-year compound annual growth rate (CAGR) favors LFST at 1.4% vs LAW's -11.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -45.5% | +27.2% |
| 1-Year ReturnPast 12 months | +9.5% | +60.6% |
| 3-Year ReturnCumulative with dividends | -31.1% | +4.1% |
| 5-Year ReturnCumulative with dividends | -90.3% | -59.6% |
| 10-Year ReturnCumulative with dividends | -90.3% | -59.6% |
| CAGR (3Y)Annualised 3-year return | -11.7% | +1.4% |
Risk & Volatility
Evenly matched — LAW and LFST each lead in 1 of 2 comparable metrics.
Risk & Volatility
LAW is the less volatile stock with a 0.96 beta — it tends to amplify market swings less than LFST's 1.20 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LFST currently trades 99.6% from its 52-week high vs LAW's 43.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.67x | 1.06x |
| 52-Week HighHighest price in past year | $9.11 | $8.89 |
| 52-Week LowLowest price in past year | $2.45 | $3.74 |
| % of 52W HighCurrent price vs 52-week peak | +43.6% | +99.6% |
| RSI (14)Momentum oscillator 0–100 | 41.5 | 60.4 |
| Avg Volume (50D)Average daily shares traded | 376K | 2.9M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates LAW as "Hold" and LFST as "Buy". Consensus price targets imply 126.4% upside for LAW (target: $9) vs 5.1% for LFST (target: $9).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $9.00 | $9.30 |
| # AnalystsCovering analysts | 11 | 11 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.0% | 0.0% |
LFST leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). LAW leads in 1 (Valuation Metrics). 1 tied.
LAW vs LFST: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is LAW or LFST a better buy right now?
For growth investors, LifeStance Health Group, Inc.
(LFST) is the stronger pick with 13. 9% revenue growth year-over-year, versus 8. 3% for CS Disco, Inc. (LAW). LifeStance Health Group, Inc. (LFST) offers the better valuation at 442. 5x trailing P/E (121. 1x forward), making it the more compelling value choice. Analysts rate LifeStance Health Group, Inc. (LFST) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — LAW or LFST?
Over the past 5 years, LifeStance Health Group, Inc.
(LFST) delivered a total return of -59. 6%, compared to -90. 3% for CS Disco, Inc. (LAW). Over 10 years, the gap is even starker: LFST returned -64. 9% versus LAW's -90. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — LAW or LFST?
By beta (market sensitivity over 5 years), CS Disco, Inc.
(LAW) is the lower-risk stock at 0. 67β versus LifeStance Health Group, Inc. 's 1. 06β — meaning LFST is approximately 57% more volatile than LAW relative to the S&P 500.
04Which is growing faster — LAW or LFST?
By revenue growth (latest reported year), LifeStance Health Group, Inc.
(LFST) is pulling ahead at 13. 9% versus 8. 3% for CS Disco, Inc. (LAW). On earnings-per-share growth, the picture is similar: LifeStance Health Group, Inc. grew EPS 113. 3% year-over-year, compared to 22. 6% for CS Disco, Inc.. Over a 3-year CAGR, LFST leads at 18. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — LAW or LFST?
LifeStance Health Group, Inc.
(LFST) is the more profitable company, earning 0. 7% net margin versus -28. 3% for CS Disco, Inc. — meaning it keeps 0. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LFST leads at 1. 8% versus -30. 7% for LAW. At the gross margin level — before operating expenses — LAW leads at 74. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is LAW or LFST more undervalued right now?
Analyst consensus price targets imply the most upside for LAW: 126.
4% to $9. 00.
07Which pays a better dividend — LAW or LFST?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is LAW or LFST better for a retirement portfolio?
For long-horizon retirement investors, CS Disco, Inc.
(LAW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 67)). Both have compounded well over 10 years (LAW: -90. 0%, LFST: -64. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between LAW and LFST?
These companies operate in different sectors (LAW (Technology) and LFST (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.